New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection
- PMID: 29463007
- PMCID: PMC5836052
- DOI: 10.3390/brainsci8020033
New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection
Abstract
Neurodegeneration is a complex process that leads to irreversible neuronal damage and death in spinal cord injury (SCI) and various neurodegenerative diseases, which are serious, debilitating conditions. Despite exhaustive research, the cause of neuronal damage in these degenerative disorders is not completely understood. Elevation of cell surface α-enolase activates various inflammatory pathways, including the production of pro-inflammatory cytokines, chemokines, and some growth factors that are detrimental to neuronal cells. While α-enolase is present in all neurological tissues, it can also be converted to neuron specific enolase (NSE). NSE is a glycolytic enzyme found in neuronal and neuroendocrine tissues that may play a dual role in promoting both neuroinflammation and neuroprotection in SCI and other neurodegenerative events. Elevated NSE can promote ECM degradation, inflammatory glial cell proliferation, and actin remodeling, thereby affecting migration of activated macrophages and microglia to the injury site and promoting neuronal cell death. Thus, NSE could be a reliable, quantitative, and specific marker of neuronal injury. Depending on the injury, disease, and microenvironment, NSE may also show neurotrophic function as it controls neuronal survival, differentiation, and neurite regeneration via activation of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling pathways. This review discusses possible implications of NSE expression and activity in neuroinflammation, neurodegeneration, and neuroprotection in SCI and various neurodegenerative diseases for prognostic and therapeutic potential.
Keywords: cathepsin X; degeneration; gliosis; neuron specific enolase (NSE); neuroprotection; spinal cord injury (SCI).
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures
Similar articles
-
Regulation of enolase activation to promote neural protection and regeneration in spinal cord injury.Neural Regen Res. 2023 Jul;18(7):1457-1462. doi: 10.4103/1673-5374.361539. Neural Regen Res. 2023. PMID: 36571342 Free PMC article. Review.
-
Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats.Neurochem Res. 2017 Oct;42(10):2777-2787. doi: 10.1007/s11064-017-2291-z. Epub 2017 May 15. Neurochem Res. 2017. PMID: 28508172 Free PMC article.
-
Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.Metab Brain Dis. 2016 Jun;31(3):487-95. doi: 10.1007/s11011-016-9801-6. Epub 2016 Feb 5. Metab Brain Dis. 2016. PMID: 26847611 Free PMC article. Review.
-
Implications of enolase in the RANKL-mediated osteoclast activity following spinal cord injury.Biocell. 2021 Sep 1;45(6):1453-1457. doi: 10.32604/biocell.2021.017659. Biocell. 2021. PMID: 34539043 Free PMC article.
-
Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury.Neurochem Int. 2020 Oct;139:104788. doi: 10.1016/j.neuint.2020.104788. Epub 2020 Jul 8. Neurochem Int. 2020. PMID: 32650031 Free PMC article.
Cited by
-
GFAP and Neuron Specific Enolase (NSE) in the Serum of Suicide Attempters.Med J Islam Repub Iran. 2022 Sep 7;36:103. doi: 10.47176/mjiri.36.103. eCollection 2022. Med J Islam Repub Iran. 2022. PMID: 36447551 Free PMC article.
-
Parthenolide ameliorates 3-nitropropionic acid-induced Huntington's disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting.Mol Med. 2024 Sep 26;30(1):158. doi: 10.1186/s10020-024-00917-5. Mol Med. 2024. PMID: 39327568 Free PMC article.
-
Extralobar pulmonary sequestration with elevated serum neuron-specific enolase: A case report and review of the literature.Medicine (Baltimore). 2020 Oct 2;99(40):e22574. doi: 10.1097/MD.0000000000022574. Medicine (Baltimore). 2020. PMID: 33019470 Free PMC article. Review.
-
Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors.Int J Mol Sci. 2022 Feb 4;23(3):1784. doi: 10.3390/ijms23031784. Int J Mol Sci. 2022. PMID: 35163706 Free PMC article.
-
A Missing Link between Neuron Specific Enolase Release and Poor Prognosis in Aging Patients with B-cell Lymphoma.J Clin Cell Immunol. 2018;9(3):e121. doi: 10.4172/2155-9899.1000e121. Epub 2018 May 15. J Clin Cell Immunol. 2018. PMID: 30464859 Free PMC article. No abstract available.
References
-
- Shimizu A., Suzuki F., Kato K. Characterization of alpha alpha, beta beta, gamma gamma and alpha gamma human enolase isozymes, and preparation of hybrid enolases (alpha gamma, beta gamma and alpha beta) from homodimeric forms. Biochim. Biophys. Acta. 1983;748:278–284. doi: 10.1016/0167-4838(83)90305-9. - DOI - PubMed
-
- Piast M., Kustrzeba-Wojcicka I., Matusiewicz M., Banas T. Molecular evolution of enolase. Acta Biochim. Pol. 2005;52:507–513. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources